Eptifibatide in peripheral vascular interventions: results of the Integrilin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial.

Autor: Shammas NW; Midwest Cardiovascular Research Foundation, Davenport, Iowa, USA., Dippel EJ, Lemke JH, Robken J, Kirchner HL, Takes V, Kapalis MJ, Palabrica T

Publikováno v: The Journal of invasive cardiology [J Invasive Cardiol] 2006 Jan; Vol. 18 (1), pp. 6-12.

Clinical and angiographic predictors of restenosis following renal artery stenting.

Autor: Shammas NW; Genesis Heart Institute, Cardiovascular Medicine, PC, St. Ambrose University, Davenport, IA 52803, USA. shammas@mchsi.com, Kapalis MJ, Dippel EJ, Jerin MJ, Lemke JH, Patel P, Harris M

Publikováno v: The Journal of invasive cardiology [J Invasive Cardiol] 2004 Jan; Vol. 16 (1), pp. 10-3.

In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant.

Autor: Shammas NW; Cardiovascular Medicine, PC, Genesis Heart Institute, 1236 E. Rusholme, Suite 300, Davenport, IA 52803, USA. shammas@mchsi.com, Lemke JH, Dippel EJ, McKinney DE, Takes VS, Youngblut M, Harris M, Harb C, Kapalis MJ, Holden J

Publikováno v: The Journal of invasive cardiology [J Invasive Cardiol] 2003 May; Vol. 15 (5), pp. 242-6.